MTOR and neoplasm: One major adaptive mechanism that grants to tumor cells the capacity to survive mTOR inhibition by Rapalogs consists of the activation of the pro-survival RTK/PI3K/Akt signaling axis, due to interruption of the negative feedback emanating from mTORC1 (reviewed by [242]).